These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9723380)

  • 1. Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients.
    Carmellini M; Matteucci E; Boggi U; Cecconi S; Giampietro O; Mosca F
    Transplant Proc; 1998 Aug; 30(5):2034-5. PubMed ID: 9723380
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients.
    Carmellini M; Frosini F; Filipponi F; Boggi U; Mosca F
    Transplantation; 1997 Jul; 64(1):164-6. PubMed ID: 9233719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Ho A; Leung R; Lai CK; Chan TH; Chan CH
    Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic].
    Briskin BS; Khachatrian NN; Nekrasova NI; Kuznetsov EV; Suplotova AA; Sosnovikova OG
    Khirurgiia (Mosk); 2000; (9):56-61. PubMed ID: 11026205
    [No Abstract]   [Full Text] [Related]  

  • 5. Tubular damage and impairment of renal function in transplanted kidneys.
    Donadio C; Puccini R; Lucchesi A; Giordani R; Rizzo G
    Transplant Proc; 1998 Aug; 30(5):2036-7. PubMed ID: 9723381
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D; Bacci S; Bosi A; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi Ferrini P
    J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic Nocardia asteroides infection with endocardial involvement in a patient undergoing immunosuppressive therapy].
    Niehues R; Schlüter S; Kramer A; Klein RM; Strauer BE; Schaal KP; Horstkotte D
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1390-5. PubMed ID: 8964228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA
    Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract]   [Full Text] [Related]  

  • 9. Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.
    Tejedor A; Torres AM; Castilla M; Lazaro JA; de Lucas C; Caramelo C
    Curr Med Res Opin; 2007 Mar; 23(3):505-13. PubMed ID: 17355732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
    Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
    Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients.
    Cox CE; Holloway WJ; Geckler RW
    Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
    Tonelli F
    Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.
    Romanelli G; Cravarezza P
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
    Edwards SJ; Emmas CE; Campbell HE
    Curr Med Res Opin; 2005 May; 21(5):785-94. PubMed ID: 15969878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A; Meli EZ; Mazzocchi P; Speranza V
    Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
    Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
    Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.
    Sundberg AK; Smith LD; Somerville KT; Cox R; Sherbotie JR
    Transplant Proc; 2002 Aug; 34(5):1951-2. PubMed ID: 12176640
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
    Solomkin JS; Wilson SE; Christou NV; Rotstein OD; Dellinger EP; Bennion RS; Pak R; Tack K
    Ann Surg; 2001 Jan; 233(1):79-87. PubMed ID: 11141229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.